The once-daily pill, currently under investigation, is being studied for adults with type 2 diabetes who are not on any ...

The results Lilly is reporting for its oral pill come as another big drug company, Pfizer, has decided to discontinue its ...

Nearly 40 generic medications targeting heart and brain illnesses produced by Glenmark Pharmaceuticals have been recalled by ...

Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...

Older adults living with Type 2 diabetes face more than just blood sugar concerns. New research shows some of the most ...

A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

Imagine a world where managing type 2 diabetes doesn't involve needles. A new experimental pill might just change the game, ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

A daily weight loss pill that works like breakthrough fat jab Ozempic could be available in the UK as early as next year.

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

When it comes to oral semaglutide, the OASIS-1 trial showed that it led to a 15.1% reduction in body weight. But this was at ...

Eli Lilly's new oral weight loss pill, orforglipron, shows promise in Phase 3 trials, offering a convenient alternative to ...